Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 57
Filtrar
3.
Nucl Med Commun ; 43(6): 625-630, 2022 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-35362693

RESUMO

Keloid, hypertrophic scars and basal cell carcinoma (BCC) falls under the category of non-melanoma skin cancer. Intralesional steroids, external beam radiation therapy, 5-Fluorouracil, cryotherapy, laser, etc are the available treatment options. However, recurrence has been reported with each type of treatment mode. In the present article, various treatment modes have been discussed and institutional experience of Rhenium-188 skin patches for the treatment of keloids and BCC has been discussed.


Assuntos
Cicatriz Hipertrófica , Queloide , Medicina Nuclear , Anormalidades da Pele , Cicatriz Hipertrófica/patologia , Cicatriz Hipertrófica/terapia , Crioterapia , Humanos , Queloide/diagnóstico por imagem , Queloide/radioterapia , Anormalidades da Pele/terapia
4.
Am J Med Genet A ; 185(7): 2150-2152, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-33836117

RESUMO

Poikiloderma with neutropenia (PN), is a rare autosomal recessive condition with many associated complications and manifestations. Here we present a patient with confirmed PN who is of one-quarter Chucktaw or Cherokee heritage with no known descent from the Navajo tribe. The patient's condition was complicated by chronic bilateral lower limb cellulitis and associated osteomyelitis which was unresponsive to extensive antibiotic regimens. Subsequent treatment with hyperbaric oxygen therapy (HBOT) was successful. To date, no author has reported on the treatment of recurrent cellulitis using HBOT in this patient population. Based on our experience, HBOT should be considered in patients with PN.


Assuntos
Celulite (Flegmão)/terapia , Oxigenoterapia Hiperbárica/métodos , Neutropenia/terapia , Osteomielite/terapia , Anormalidades da Pele/terapia , Adulto , Celulite (Flegmão)/genética , Celulite (Flegmão)/fisiopatologia , Feminino , Humanos , Neutropenia/genética , Neutropenia/fisiopatologia , Osteomielite/genética , Osteomielite/patologia , Anormalidades da Pele/genética , Anormalidades da Pele/fisiopatologia , Adulto Jovem
5.
Am J Med Genet A ; 185(2): 625-630, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33258232

RESUMO

Self-improving dystrophic epidermolysis bullosa is a rare subtype of dystrophic epidermolysis bullosa (DEB) characterized by significant improvement in skin fragility within the first few years of life. Genetic inheritance has previously been reported as autosomal dominant or recessive with both forms harboring mutations in COL7A1. To date, there have been no reports of this rare clinical entity from various Southeast Asian ethnicities. Here, we describe the clinical and molecular features of five patients from the Southeast Asia region who presented with predominantly acral-distributed blisters and erosions in the first few days of life. Blistering resolved over several months, without appearance of new blisters. By immunofluorescence, intraepidermal retention of Type VII collagen was observed in all patient skin biopsies when investigated with antibody staining. Genetic analysis of four patients revealed pathogenic variants in COL7A1 which have not been previously reported. The clinical diagnosis in these rare patients is confirmed with molecular histology and genetic characterization.


Assuntos
Colágeno Tipo VII/genética , Epidermólise Bolhosa Distrófica/genética , Predisposição Genética para Doença , Anormalidades da Pele/genética , Sudeste Asiático/epidemiologia , Biópsia , Pré-Escolar , Epidermólise Bolhosa Distrófica/diagnóstico , Epidermólise Bolhosa Distrófica/fisiopatologia , Epidermólise Bolhosa Distrófica/terapia , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Anormalidades da Pele/diagnóstico , Anormalidades da Pele/fisiopatologia , Anormalidades da Pele/terapia
6.
Acta Derm Venereol ; 100(5): adv00053, 2020 02 12.
Artigo em Inglês | MEDLINE | ID: mdl-32039456

RESUMO

The term skin fragility disorders describes a group of conditions in which the structural integrity of the skin is compromised and its resistance to external shear forces diminished. Skin fragility can have different causes, ranging from genetic variations to inflammatory or physical phenomena. The genetic skin fragility disorders, collectively called epidermolysis bullosa, serve as a paradigm for the study of causes and mechanisms of skin fragility. Recent biomedical research has revealed substantial genetic heterogeneity of the epidermolysis bullosa group, delivered ample new knowledge on its pathophysiology, and facilitated the design of evidence-based therapeutic strategies. The therapy development process extends from in vitro testing to preclinical validation in animal models, and clinical trials. This article reviews different approaches to curative and symptom-relief therapies, and appraises their status and perspectives for clinical implementation.


Assuntos
Epidermólise Bolhosa/genética , Epidermólise Bolhosa/terapia , Predisposição Genética para Doença , Terapia Genética/métodos , Anormalidades da Pele/genética , Anormalidades da Pele/terapia , Terapia Baseada em Transplante de Células e Tecidos/métodos , Gerenciamento Clínico , Epidermólise Bolhosa/patologia , Medicina Baseada em Evidências , Feminino , Previsões , Alemanha , Humanos , Masculino , Índice de Gravidade de Doença , Anormalidades da Pele/patologia , Resultado do Tratamento
7.
Clin Exp Dermatol ; 45(2): 141-146, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31529496

RESUMO

Vascular anomalies can cause both emotional and physical distress to patients, particularly children. The paediatric laser service at Great Ormond Street Hospital (GOSH) treats a range of dermatological conditions including a variety of vascular anomalies, excess hair growth and disfiguring scars. The laser team at GOSH has 25 years of experience in treating a wide variety of paediatric dermatological conditions using various laser therapies. With over 600 new referrals for laser therapy and over 1000 laser procedures each year the GOSH laser team has vast amounts of experience with both common and rare conditions. Excellent clinical outcomes continue to be delivered, and new treatment therapies are constantly being developed to treat more recalcitrant lesions. The adverse effect rates experienced by the GOSH laser patients have been decreasing over the past two decades, reaching the low rate of 0.8% per treated patients per year. This remarkable achievement has been continuously improved by integrating specific and standardized laser protocols for each patient treated, to ensure efficacious and safe laser treatment delivery. Treating vascular anomalies with laser therapy creates significant positive results among the paediatric population, thus laser therapy at GOSH makes a significant impact upon children's lives with both rare and common vascular anomalies.


Assuntos
Terapia a Laser , Anormalidades da Pele/terapia , Malformações Vasculares/terapia , Criança , Pré-Escolar , Feminino , Hemangioma/terapia , Humanos , Terapia a Laser/efeitos adversos , Terapia a Laser/métodos , Masculino , Síndromes Neurocutâneas/terapia
9.
Am J Med Genet A ; 179(6): 915-926, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-30868735

RESUMO

Mutations in the CHRNG gene cause autosomal recessive multiple pterygium syndrome (MPS). Herein we present a long-term follow-up of seven patients with CHRNG-related nonlethal MPS and we compare them with the 57 previously published patients. The objective is defining not only the clinical, histopathological, and molecular genetic characteristics, but also the type and degree of muscle involvement on whole-body magnetic resonance imaging (WBMRI). CHRNG mutations lead to a distinctive phenotype characterized by multiple congenital contractures, pterygium, and facial dysmorphism, with a stable clinical course over the years. Postnatal abnormalities at the neuromuscular junction were observed in the muscle biopsy of these patients. WBMRI showed distinctive features different from other arthrogryposis multiple congenita. A marked muscle bulk reduction is the predominant finding, mostly affecting the spinal erector muscles and gluteus maximus. Fatty infiltration was only observed in deep paravertebral muscles and distal lower limbs. Mutations in CHRNG are mainly located at the extracellular domain of the protein. Our study contributes to further define the phenotypic spectrum of CHRNG-related nonlethal MPS, including muscle imaging features, which may be useful in distinguishing it from other diffuse arthrogryposis entities.


Assuntos
Anormalidades Múltiplas/diagnóstico , Anormalidades Múltiplas/genética , Estudos de Associação Genética , Predisposição Genética para Doença , Hipertermia Maligna/diagnóstico , Hipertermia Maligna/genética , Mutação , Fenótipo , Receptores Nicotínicos/genética , Anormalidades da Pele/diagnóstico , Anormalidades da Pele/genética , Anormalidades Múltiplas/terapia , Adolescente , Alelos , Substituição de Aminoácidos , Biópsia , Pré-Escolar , Ecocardiografia , Feminino , Estudos de Associação Genética/métodos , Testes Genéticos , Genótipo , Humanos , Imageamento por Ressonância Magnética , Masculino , Hipertermia Maligna/terapia , Modelos Moleculares , Músculo Esquelético/diagnóstico por imagem , Músculo Esquelético/patologia , Conformação Proteica , Receptores Nicotínicos/química , Anormalidades da Pele/terapia , Relação Estrutura-Atividade , Imagem Corporal Total
10.
BMC Ophthalmol ; 18(1): 252, 2018 Sep 18.
Artigo em Inglês | MEDLINE | ID: mdl-30227830

RESUMO

BACKGROUND: To report a patient who presented with bluish scleral discoloration, keratoconus, and progressive high myopia. CASE PRESENTATION: A 6-year-old Chinese female patient presented with a significant bluish discoloration of the sclera in both eyes and extreme corneal thinning with anterior corneal protrusion. General pediatric physical examination was normal for all systems and no genetic disorders known were observed. CONCLUSIONS: We aim to highlight the importance of diagnosis and treatment of patients suffering from Brittle cornea syndrome. Timely diagnosis and early provision of protective glasses seem to be the most important step in treating BCS. To our knowledge, this is the first case of BCS being reported in the Asia area.


Assuntos
Anormalidades do Olho/patologia , Instabilidade Articular/congênito , Anormalidades da Pele/patologia , Criança , Diagnóstico Diferencial , Anormalidades do Olho/terapia , Dispositivos de Proteção dos Olhos , Óculos , Feminino , Humanos , Instabilidade Articular/patologia , Instabilidade Articular/terapia , Ceratocone/patologia , Miopia Degenerativa/patologia , Esclera/patologia , Anormalidades da Pele/terapia
11.
Rev. méd. Minas Gerais ; 28: [1-5], jan.-dez. 2018.
Artigo em Português | LILACS | ID: biblio-970385

RESUMO

Micose fungoide é uma neoplasia dos linfócitos T helper que afeta a pele e geralmente não apresenta manifestações extracutâneas por muitos anos. Já a micose fungoide hipocromiante (MFH) corresponde a um subtipo daquela com melhor prognóstico e que se apresenta com lesões hipocrômicas a acrômicas, com distribuição mais comum em tronco, regiões proximais de extremidades e cintura pélvica. O diagnóstico é firmado pela apresentação clínica aliada à histopatologia, que evidencia epidermotropismo com linfócitos atípicos. A doença geralmente apresenta boa resposta ao tratamento, o qual pode ser realizado com fototerapia com raios ultravioleta A (UVA), ultravioleta B (UVB), mostarda nitrogenada tópica, carmustina tópica e irradiação cutânea com elétrons. Descreve-se o caso de uma criança com máculas hipocrômicas que surgiram inicialmente no abdome, posteriormente se estendendo para raiz de coxas e região inguinal. As lesões apresentavam descamação fina, porém sem eritema ou prurido e ausência de linfonodomegalia palpável. A princípio o caso foi conduzido como eczemátide hipocromiante, mas o paciente apresentou agravamento importante das lesões em poucos meses apesar do tratamento, sendo assim, aventada a hipótese diagnóstica de MFH. Duas biópsias de pele foram realizadas, e os exames anatomopatológico e imunohistoquímica evidenciaram certo epidermotropismo, mas sem atipia de linfócitos. Foi orientado helioterapia domiciliar, com exposição corporal de 10 minutos no período da manhã, além do uso de emolientes e cuidados gerais com a pele, com relativa boa resposta. O acompanhamento é semestral e caso haja modificação do quadro, a biópsia com estudo histopatológico e a imunohistoquímica serão realizados novamente. (AU)


Mycosis fungoides is a type of cancer of the T helper lymphocytes that affects the skin and generally has no extracutaneous manifestations for many years. Otherwise, hypopigmented mycosis fungoides corresponds to a subtype with better prognosis and presents as hypopigmented or achromatic lesions, with more widespread distribution in the trunk, proximal parts of extremities and pelvic girdle. The diagnosis is confirmed by clinical presentation and histopathology, which shows epidermotropism and atypical lymphocytes. The disease usually show good response to treatment, which is performed with phototherapy with ultraviolet A (UVA), ultraviolet B (UVB), topical nitrogen mustard, topical carmustine and cutaneous irradiation with electrons. We describe the case of a child with hypochromic taint that initially appeared in the abdomen, later extending to root thighs and groin. The lesions had fine scaling, absence of erythema or itching, without the presence of palpable lymph node enlargement. At first the case was conducted as pytiriasis alba, but the patient had significant aggravation of injuries in a few months in spite of the treatment, thus mooted diagnosis of hypopigmented mycosis fungoides. Two skin biopsies were performed, and the histological and immunohistochemical tests showed epidermotropism but no atypia of lymphocytes. It was guided home heliotherapy, with body exposure of 10 minutes in the morning, besides the use of emollients and general skin care, with a relatively good response. The follow-up is bi-annually and if there is a modification in the condition, the biopsy with histopathological study and immunohistochemistry will be performed again. (AU)


Assuntos
Humanos , Terapia Ultravioleta/estatística & dados numéricos , Micose Fungoide/radioterapia , Linfoma , Anormalidades da Pele/terapia , Micose Fungoide/tratamento farmacológico , Terapêutica/métodos , Criança
13.
Rev. argent. cir. plást ; 23(1): 21-26, 20170000. fig
Artigo em Espanhol | LILACS, BINACIS | ID: biblio-1391795

RESUMO

La piel es asiento frecuente de injurias en especial traumáticas o neoplásicas, surgiendo la necesidad de la reconstrucción de la brecha quirúrgica. Existen múltiples opciones de reconstrucción y su uso dependerá del tamaño del defecto quirúrgico a reparar y de la experiencia y preferencia del cirujano tratante. Presentaremos al colgajo romboidal de Limberg y sus variantes como una técnica reconstructiva de gran utilidad para cubrir defectos cutáneos en cara y otras partes del cuerpo respetando la función y estética de la región.


The skin is a frequent seat of injuries especially traumatic or neoplastic, arising the need for reconstruction of the surgical gap. There are multiple reconstruction options and their use will depend on the size of the surgical defect to be repaired and on the experience and preference of the treating surgeon. We will present the rhombus Limberg fl ap and its variants as a reconstructive technique of great utility to cover skin defects in the face and other parts of the body respecting the function and aesthetics of the region.


Assuntos
Anormalidades da Pele/terapia , Retalhos Cirúrgicos/transplante , Procedimentos de Cirurgia Plástica/métodos , Procedimentos Cirúrgicos Dermatológicos/métodos
14.
Eklem Hastalik Cerrahisi ; 27(3): 171-4, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27902173

RESUMO

Escobar (multiple pterygium) syndrome is progressive and a very rare syndrome. It is generally characterized by multiple pterygia that are found in the cervical, antecubital and popliteal regions. In this report, we present the treatment management of a 14-year-old case with late stage Escobar syndrome who was admitted due to multiple pterygia and bilateral knee contractures. The treatment of this case was conducted in collaboration with the department of orthopedics and the department of physical therapy. The treatment of the case was done in three stages: soft tissue procedures, femoral recurvatum osteotomy and triple arthrodesis, respectively. In addition to all these, the patient did intensive physical therapy for one year. As a result of the operations and physical therapy, adequate muscle strength was obtained.


Assuntos
Anormalidades Múltiplas/diagnóstico , Anormalidades Múltiplas/terapia , Comunicação Interdisciplinar , Colaboração Intersetorial , Hipertermia Maligna/diagnóstico , Hipertermia Maligna/terapia , Anormalidades da Pele/diagnóstico , Anormalidades da Pele/terapia , Adolescente , Terapia Combinada , Humanos , Turquia
15.
Actas dermo-sifiliogr. (Ed. impr.) ; 107(7): 591-596, sept. 2016. tab, ilus
Artigo em Inglês | IBECS | ID: ibc-155538

RESUMO

BACKGROUND: Port wine stains (PWSs) are commonly treated by the pulsed dye laser. However, treatment of hypertrophic or resistant PWSs is a major therapeutic challenge. The long-pulsed Alexandrite laser could be a safe and effective treatment for resistant PWSs, due to an increase depth of penetration of 50-75% over PDL. OBJECTIVE: The aim of this study was to assess the efficacy and safety of a long-pulsed Alexandrite laser in patients with hypertrophic, dark and/or resistant PWSs. Pink pale resistant PWS were excluded from the study. METHODS: Twenty-one patients (age 20-75 years), phototypes I-IV on the Fitzpatrick scale, with PDL dark resistant PWSs were treated with long-pulsed Alexandrite laser. We excluded high phototypes and PDL pink resistant PWSs. All patients were treated with 3 laser sessions at settings of 3-ms pulse duration, 10-mm spot, 35-55J/cm2, with cooling (Dynamic Cooling Device 50 ms with delay 30 ms). Laser sessions were repeated approximately every 2 months. Three dermatologists evaluated treatment effectiveness by means of photographs of the patients before and after laser treatment (scale from 0 to 4). Adverse events were registered. Patient satisfaction was also assessed (scale from 0 to 10). RESULTS: Mean global improvement was rated as 2.28. Long-lasting side effects included minimal scarring after blistering in 1 patient. Mean patient satisfaction was 8.5. CONCLUSIONS: Our study concludes that long-pulsed Alexandrite laser was effective for treatment of resistant PWSs, although the therapeutical window is narrow with this treatment


ANTECEDENTES: Las manchas en vino de oporto (MVO) son normalmente tratadas con láser de colorante pulsado. Sin embargo, el tratamiento de MVO hipertróficas o resistentes continúa siendo un importante reto terapéutico. El láser de Alejandrita de pulso largo podría ser un método seguro y eficaz para el tratamiento de estas lesiones, debido a que la profundidad que alcanza puede superar entre un 50-75% al láser de colorante pulsado. OBJETIVO: El objetivo de este estudio fue evaluar la eficacia y la seguridad del láser de Alejandrita de pulso largo en pacientes con MVO hipertróficas y/o resistentes. Los pacientes con MVO resistentes de color rosa pálido fueron excluidos del estudio. MÉTODOS: Veintiún pacientes (Edades entre 20-75 años), fototipos I-IV en la escala Fitzpatrick, con MVO oscuras, resistentes al tratamiento con láser de colorante pulsado fueron tratados con láser de Alejandrita de pulso largo. Se excluyeron los fototipos altos y las MVO de color rosado pálido. Todos los pacientes fueron tratados con 3 sesiones de láser con los siguientes parámetros: duración de pulso de 3 ms, spot de 10 mm de diámetro, fluencias comprendidas entre 35 y 55 J/cm2, con refrigeración (Dynamic Coolong Device). El intervalo de tiempo entre sesiones fue de 2 meses aproximadamente. Tres dermatólogos evaluaron la efectividad del tratamiento a través de las fotografías de los pacientes antes y después del tratamiento con láser (escala de 0 a 4). Se registraron los eventos adversos acontecidos. La satisfacción del paciente también se evaluó (escala de 0 a 10). RESULTADOS: La mejoría global media fue de 2,28. Los efectos adversos duraderos fueron lesiones cicatriciales mínimas en un paciente. La satisfacción media de los pacientes fue de 8,5. CONCLUSIONES: Nuestro estudio concluye que el láser de Alejandrita de pulso largo puede ser eficaz en el tratamiento de MVO resistentes, aunque la ventana terapéutica es estrecha con este tratamiento


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Doenças do Cabelo/radioterapia , Doenças do Cabelo , Mancha Vinho do Porto/terapia , Anormalidades da Pele/terapia , Terapia a Laser/instrumentação , Terapia a Laser/métodos , Terapia a Laser , Lasers de Estado Sólido/uso terapêutico , Pele/anatomia & histologia , Pele/patologia , Pele/efeitos da radiação , Resultado do Tratamento , Avaliação de Eficácia-Efetividade de Intervenções , Estudos Prospectivos
17.
Sci Rep ; 6: 27315, 2016 06 06.
Artigo em Inglês | MEDLINE | ID: mdl-27265476

RESUMO

Non-coding RNAs provide additional regulatory layers to gene expression as well as the potential to being exploited as therapeutic tools. Non-coding RNA-based therapeutic approaches have been attempted in dominant diseases, however their use for treatment of genetic diseases caused by insufficient gene dosage is currently more challenging. SINEUPs are long antisense non-coding RNAs that up-regulate translation in mammalian cells in a gene-specific manner, although, so far evidence of SINEUP efficacy has only been demonstrated in in vitro systems. We now show that synthetic SINEUPs effectively and specifically increase protein levels of a gene of interest in vivo. We demonstrated that SINEUPs rescue haploinsufficient gene dosage in a medakafish model of a human disorder leading to amelioration of the disease phenotype. Our results demonstrate that SINEUPs act through mechanisms conserved among vertebrates and that SINEUP technology can be successfully applied in vivo as a new research and therapeutic tool for gene-specific up-regulation of endogenous functional proteins.


Assuntos
Produtos Biológicos/administração & dosagem , Regulação da Expressão Gênica/efeitos dos fármacos , Doenças Genéticas Ligadas ao Cromossomo X/terapia , Terapia Genética/métodos , Microftalmia/terapia , RNA Longo não Codificante/administração & dosagem , Anormalidades da Pele/terapia , Animais , Produtos Biológicos/metabolismo , Modelos Animais de Doenças , Humanos , Oryzias , RNA Longo não Codificante/genética , RNA Longo não Codificante/metabolismo , Resultado do Tratamento
18.
Del Med J ; 88(10): 308-310, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29894032

RESUMO

The patient is a unique case presenting with presumed Restrictive Dermopathy (RD) and intracranial and adrenal calcifications, an association not previously described in the literature. This case postulates the possibility of additional radiographic features that can be included in the spectrum of RD or as secondary events from the underlying pathophysiology of RD.


Assuntos
Acidose , Contratura/congênito , Cuidados para Prolongar a Vida/métodos , Anormalidades Musculoesqueléticas/diagnóstico por imagem , Radiografia/métodos , Sepse , Anormalidades da Pele/diagnóstico , Acidose/diagnóstico , Acidose/etiologia , Acidose/terapia , Contratura/complicações , Contratura/diagnóstico , Contratura/fisiopatologia , Contratura/terapia , Evolução Fatal , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Convulsões/etiologia , Convulsões/terapia , Sepse/etiologia , Sepse/fisiopatologia , Sepse/terapia , Anormalidades da Pele/complicações , Anormalidades da Pele/fisiopatologia , Anormalidades da Pele/terapia , Ultrassonografia/métodos
19.
Rev Med Brux ; 36(4): 348-57, 2015 Sep.
Artigo em Francês | MEDLINE | ID: mdl-26591323

RESUMO

INTRODUCTION: Vascular anomalies, which are erroneously categorized under the term angiomas, are a highly heterogeneous group of lesions that are poorly understood and affect a mean of 5 to 10 % of children. The fortuitous discovery of propranolol's efficacy in one of these entities has made them a topical issue. OBJECTIVES: The paper's main objective is to inform family doctors of the various types of vascular anomalies, clarify their classification, and provide a common terminology. Its secondary objective is to provide a decision tree that enables primary care doctors to avoid diagnostic pitfalls, successfully detect cases, and optimize management. METHODS: Systematic review. CONCLUSIONS: According to a recent study, 71,3 % of publications use the term hemangioma erroneously, regardless of the authors' field. The key for family doctors is to use one international classification only, that of the International Society for the Study of Vascular Anomalies (ISSVA), in order to facilitate management and comprehension between the different healthcare levels. The diagnosis of vascular anomalies is clinical in 90 % of cases, so all family doctors can, whilst using a decision tree, diagnose a vascular anomaly and refer only those that are complex for specialist care. The most common vascular anomaly is infantile hemangioma in infants, which spontaneously regresses around the age of 5-7 years in 90 % of cases. Watchful waiting and regular follow-up suffice, therefore, in such settings.


Assuntos
Anormalidades da Pele , Dermatopatias Vasculares , Malformações Vasculares , Criança , Pré-Escolar , Hemangioma/classificação , Hemangioma/diagnóstico , Hemangioma/terapia , Humanos , Anormalidades da Pele/classificação , Anormalidades da Pele/diagnóstico , Anormalidades da Pele/epidemiologia , Anormalidades da Pele/terapia , Dermatopatias Vasculares/classificação , Dermatopatias Vasculares/diagnóstico , Dermatopatias Vasculares/epidemiologia , Dermatopatias Vasculares/terapia , Neoplasias Cutâneas/classificação , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/terapia , Malformações Vasculares/classificação , Malformações Vasculares/diagnóstico , Malformações Vasculares/epidemiologia , Malformações Vasculares/terapia
20.
Gac Med Mex ; 151(5): 648-54, 2015.
Artigo em Espanhol | MEDLINE | ID: mdl-26526479

RESUMO

A previously healthy, immunocompetent 67-year-old female presented with a one-month history of general symptoms, weight loss, night fevers, and bilateral lower extremity edema. On admission she had severe anemia, acute kidney injury, and multiple lymphadenopathies. An excisional biopsy of one of the axillary lymphadenopathies confirmed hyaline-vascular Castleman's disease. This rare disease is a polyclonal lymphoproliferative disorder that affects the normal lymph node architecture. According to its location it can be divided in unicentric (localized) or multicentric disease; it can be further divided according to histopathology in hyaline-vascular or plasmatic cells variety. Clinical presentation relates more to histopathological variety than to centricity. Human herpes virus 8 is ubiquitous in this disease and, along with interleukin 6, plays an important role in pathogenesis and symptoms presentation. Surgery is the go-to treatment of localized disease, while systemic chemotherapy is the option in multicentric disease. Communication between the clinical and anatomopathological teams is crucial; lag in diagnosis can lead to futile investigations in search of other diseases and delay in treatment.


Assuntos
Hiperplasia do Linfonodo Gigante/complicações , Diarreia/complicações , Oftalmopatias Hereditárias/complicações , Enteropatias/complicações , Anormalidades da Pele/complicações , Doenças Vasculares/complicações , Idoso , Hiperplasia do Linfonodo Gigante/diagnóstico , Hiperplasia do Linfonodo Gigante/terapia , Diarreia/diagnóstico , Diarreia/terapia , Oftalmopatias Hereditárias/diagnóstico , Oftalmopatias Hereditárias/terapia , Feminino , Humanos , Imunocompetência , Enteropatias/diagnóstico , Enteropatias/terapia , Anormalidades da Pele/diagnóstico , Anormalidades da Pele/terapia , Doenças Vasculares/diagnóstico , Doenças Vasculares/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...